دورية أكاديمية

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.

التفاصيل البيبلوغرافية
العنوان: Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.
المؤلفون: Vera Aguilera, Jesus, Paludo, Jonas, McWilliams, Robert R., Zhang, Henan, Li, Ying, Kumar, Anagha B., Failing, Jarrett, Kottschade, Lisa A., Block, Matthew S., Markovic, Svetomir N., Dong, Haidong, Dronca, Roxana S., Yan, Yiyi
المصدر: Melanoma Research; Aug2020, Vol. 30 Issue 4, p364-375, 12p
قاعدة البيانات: Complementary Index
الوصف
تدمد:09608931
DOI:10.1097/CMR.0000000000000669